Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jazz Pharmaceuticals (JAZZ) has issued an update.
Catherine Sohn, Pharm.D. has informed Jazz Pharmaceuticals that she will retire and not seek re-election to the company’s board at the upcoming 2024 annual meeting. Her departure is amicable, with no disputes or disagreements with the company’s operations, policies, or practices mentioned as a reason for her retirement.
Find detailed analytics on JAZZ stock on TipRanks’ Stock Analysis page.